octreotide
RxNorm concept 7617, ingredient (in).
- RxCUI
- 7617
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/7617 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Sandostatin (BN, has tradename)
- Bynfezia (BN, has tradename)
- Mycapssa (BN, has tradename)
- octreotide 0.05 MG/ML (SCDC, ingredient of)
- octreotide 0.1 MG/ML (SCDC, ingredient of)
- octreotide 0.2 MG/ML (SCDC, ingredient of)
- octreotide 0.5 MG/ML (SCDC, ingredient of)
- octreotide 1 MG/ML (SCDC, ingredient of)
- octreotide Injectable Solution (SCDF, ingredient of)
- octreotide Prefilled Syringe (SCDF, ingredient of)
- octreotide Injectable Product (SCDG, ingredient of)
- octreotide Injection (SCDF, ingredient of)
- octreotide 20 MG (SCDC, ingredient of)
- octreotide 10 MG (SCDC, ingredient of)
- octreotide 30 MG (SCDC, ingredient of)
- octreotide 2.5 MG/ML (SCDC, ingredient of)
- octreotide Pen Injector (SCDF, ingredient of)
- octreotide Oral Product (SCDG, ingredient of)
- octreotide Pill (SCDG, ingredient of)
- octreotide Delayed Release Oral Capsule (SCDF, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 7617 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/7617 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 7617. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.